105 Safety and Efficacy of Tepotinib in Advanced NSCLC Patients with MET Exon 14 Skipping Mutation or Amplification: a Tertiary Centre Retrospective Cohort
Lung Cancer(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined